Indrayani Biotech

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue25.6342.0546.0049.2542.31
Expenses23.2737.6141.4547.2340.68
EBITDA2.364.444.552.021.63
EBIT1.703.693.770.870.73
Profit Before Tax1.795.263.411.85-0.38
Net Profit1.795.263.441.44-0.45
Financial Ratios
Operating Profit Margin9.21%10.56%9.89%4.10%3.88%
Net Profit Margin6.98%12.51%7.48%2.92%-1.06%
Earning Per Share (Diluted)0.521.611.050.20-0.13
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ